arXiv · 1804.04751
Predicting influenza H3N2 vaccine efficacy from evolution of the dominant epitope
Abstract
We predict vaccine efficacy with a measure of antigenic distance between influenza A(H3N2) and candidate vaccine viruses based on amino acid substitutions in the dominant epitopes. In 2016-2017, our model predicts 19% efficacy compared to 20% observed. This tool assists candidate vaccine selection by predicting human protection against circulating strains.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Melia E. Bonomo, Michael W. Deem. 2018-04-13. Predicting influenza H3N2 vaccine efficacy from evolution of the dominant epitope. https://arxiv.org/abs/1804.04751
Cite the original work for its findings. Save a collection to share your selection of sources.